A new analysis funded by Novo Nordisk's National Changing Diabetes® Program, found that the cost of diabetes and pre-diabetes reached $218 billion in 2007, with the exploding number of cases of type 2 diabetes responsible for the majority of the costs.
According to the study, diagnosed type 2 diabetes accounted for $174.4 billion of 2007...					
				
			Tag: Prediabetes
					Compugen Ltd. announced today the discovery and experimental confirmation of a genetic marker for type 2 diabetes.  A predisposition marker is of particular value in type 2 diabetes since lifestyle plays an important role in the disease.  Following diagnosis, those at high-risk might benefit from more aggressive management either through changes in lifestyle or drug treatment.					
				
			
				
